Studying cancer drug resistance in patient derived xenograft tumor models

被引:0
|
作者
Yu, Tengfei [1 ]
Yan, Ying [1 ]
Du, Wei [1 ]
Yang, Yuefei [1 ]
Tan, Tingting [1 ]
Yang, Xuqin [1 ]
Gu, Jiali [1 ]
Hua, Liang [1 ]
Ye, Xin K. [1 ]
Gu, Zhenyu [1 ]
机构
[1] GenenDesign, Shanghai, Peoples R China
关键词
D O I
10.1158/1538-7445.AM2014-1212
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1212
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Patient-Derived Xenograft Models in Breast Cancer Research
    Na, Deukchae
    Moon, Hyeong-Gon
    TRANSLATIONAL RESEARCH IN BREAST CANCER, 2021, 1187 : 283 - 301
  • [32] Zebrafish patient tumor-derived xenograft models synergize with mouse-PDX models for understanding variation in anti-cancer drug responses
    Ali, Zaheer
    Vildevall, Malin
    Nilsson, Anna
    Schueler, Julia
    Fahlgren, Anna
    De Jensen, Lasse
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Integrative genomic analysis of drug resistance in MET exon 14 skipping lung cancer using patient-derived xenograft models
    Xu, Yunhua
    Gu, Linping
    Li, Yingqi
    Zhao, Ruiying
    Jian, Hong
    Xie, Wenhui
    Liu, Liu
    Wu, Huiwen
    Ren, Fang
    Han, Yuchen
    Lu, Shun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models
    Chen, Lei
    Pan, Xiaoyong
    Zhang, Yu-Hang
    Hu, Xiaohua
    Feng, KaiYan
    Huang, Tao
    Cai, Yu-Dong
    FRONTIERS IN GENETICS, 2019, 10
  • [35] Feasibility of assessing circulating tumor cells in patient-derived xenograft tumor models
    Roy, Somdutta
    Martinez, Kevin
    Ramirez, Arturo
    Campton, Daniel
    Nordberg, Joshua
    Kaldjian, Eric
    Dylla, Scott J.
    Karsunky, Holger
    CANCER RESEARCH, 2016, 76
  • [36] Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
    Margarite D. Matossian
    Hope E. Burks
    Steven Elliott
    Van T. Hoang
    Annie C. Bowles
    Rachel A. Sabol
    Bahia Wahba
    Muralidharan Anbalagan
    Brian Rowan
    Mohamed E. Abazeed
    Bruce A. Bunnell
    Krzysztof Moroz
    Lucio Miele
    Lyndsay V. Rhodes
    Steven D. Jones
    Elizabeth C. Martin
    Bridgette M. Collins-Burow
    Matthew E. Burow
    BMC Cancer, 19
  • [37] Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
    Matossian, Margarite D.
    Burks, Hope E.
    Elliott, Steven
    Hoang, Van T.
    Bowles, Annie C.
    Sabol, Rachel A.
    Wahba, Bahia
    Anbalagan, Muralidharan
    Rowan, Brian
    Abazeed, Mohamed E.
    Bunnell, Bruce A.
    Moroz, Krzysztof
    Miele, Lucio
    Rhodes, Lyndsay V.
    Jones, Steven D.
    Martin, Elizabeth C.
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    BMC CANCER, 2019, 19 (1)
  • [38] Comparison of orthotopic and subcutaneous implantation of pancreatic cancer patient-derived xenograft models for drug development
    Fong, Sarah L.
    Pysz, Marybeth A.
    McKnight, Kristen D.
    Taylor, Nicole
    Nieu, Regina
    Markeson, Juliet
    Rammoth, Hanna
    Dilip, Archana
    Fasano, Kayla
    Janke, Emily
    Anderson, Erica
    Karsunky, Holger
    Dylla, Scott
    CANCER RESEARCH, 2017, 77
  • [39] Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models
    Prasetyanti, Pramudita R.
    van Hooff, Ander R.
    van Herwaarden, Tessa
    de Vries, Nathalie
    Kalloe, Kieshen
    Rodermond, Hans
    van Leersum, Ronald
    de Jong, Joan H.
    Franitza, Marek
    Nuernberg, Peter
    Todaro, Matilde
    Stassi, Giorgio
    Medema, Jan Paul
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (02) : 366 - 371
  • [40] Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies
    Depreeuw, Jeroen
    Hermans, Els
    Schrauwen, Stefanie
    Annibali, Daniela
    Coenegrachts, Lieve
    Thomas, Debby
    Luyckx, Mathieu
    Gutierrez-Roelens, Ilse
    Debruyne, David
    Konings, Katrien
    Moerman, Philippe
    Vergote, Ignace
    Lambrechts, Diether
    Amant, Frederic
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 118 - 126